The GI-MAP + Zonulin Test measures a variety of gastrointestinal microbiota DNA using qPCR technology. It detects microbial imbalance, microbes contributing to illness, and indicators of digestion, absorption, inflammation, and immune function.
This test also includes an add-on for the leaky gut marker zonulin.
The GI-MAP® from Diagnostic Solutions Laboratory is a comprehensive stool analysis that measures gastrointestinal microbiota DNA from a single stool sample. Using state-of-the-art, quantitative polymerase chain reaction (qPCR) technology, the GI-MAP evaluates gut pathogens, bacterial infections, yeast overgrowth, viruses, and parasites. Antibiotic resistance genes and virulence factors are also included on the test for unparalleled insight into H. pylori.
Recently, the GI-MAP has been enhanced to include an upgraded report with visual cues that allow for easier readability. Further, additional markers, including Roseburia spp., Desulfovibrio spp., and Eosinophil Activation Protein (EPX/EDN), have been added to include even greater insight into patient health.
The GI-MAP was designed to detect microbes that may be disturbing normal microbial balance or contributing to illness. To complete the picture of overall health, the GI-MAP includes key markers related to digestion, absorption, inflammation, and immune function.
An unhealthy gut can cause uncomfortable symptoms that are felt beyond the gastrointestinal (GI) tract. In fact, the root cause of brain fog, fatigue, headaches, food sensitivities, and more can often be traced back to the gut.
The GI-MAP offers impactful, quantitative results that enable practitioners to create personalized protocols that address the underlying cause(s) of uncomfortable symptoms for even the most complex patients.
qPCR offers a much more accurate way to detect and quantify clinically-relevant organisms than standard PCR, culture, microscopy, or DNA sequencing-based methods. Accurately assessing how much
of an organism's DNA is present in a patient's stool sample is essential for helping practitioners to determine the clinical significance of pathogenic organisms and dysbiosis patterns.
The GI-MAP +Zonulin allows practitioners to create personalized treatment protocols to address gut dysfunction based on which infections are urgent, which areas of the gut are already optimized, and which areas should be addressed after an infection is resolved.
Additionally, the quantification offers a remarkable ability to see how treatment modalities are working because a retest after treatment can show whether a parasite has resolved, dysbiosis has improved, and more.
Because of its comprehensive analysis of gut health, almost every patient can benefit from a GI-MAP gut health assessment. The GI-MAP is perfect for patients wishing to optimize their health, and it's a critical test for patients who have been chronically ill and frustrated without a diagnosis for years. Some conditions that warrant testing are:
The GI-MAP is analyzed from a single stool sample. The collection is easy: patients collect their stool and use the provided tools to gather some of it into a specimen vial. This vial is returned to Diagnostic Solutions via the provided prepaid envelope and then analyzed. Results are sent to your Rupa Health portal!
Due to a supply shortage, this test no longer includes antibiotic resistance genes for opportunistic/universal bacteria.
The GI-MAP is a comprehensive stool test that utilizes qPCR technology to detect parasites, bacteria, fungi, and more, allowing practitioners to create personalized treatment protocols to address gut dysfunction. This test also includes an add-on for the leaky gut marker zonulin.
Hey Practitioners! 
On December 11th, join Dr. Terry Wahls in a free live class where she'll share her groundbreaking methods for managing MS and autoimmune patients. This live session will address your most pressing questions and will take a closer look at treatment options beyond the conventional standards of care. Register here.
Register Here
.svg){kind=small}
.svg){kind=small}
